Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

OBJECTIVE: Ferumoxytol has demonstrated superior efficacy compared with oral iron in treating iron deficiency anemia in chronic kidney disease (CKD) patients. However, an economic evaluation of ferumoxytol has not been conducted. The aim of this study was to analyze the cost-effectiveness of treatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahl, Naomi V, Kaper, Robert F, Strauss, William E, Corvino, Frank A, Zivkovic, Marko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614742/
https://www.ncbi.nlm.nih.gov/pubmed/29033594
http://dx.doi.org/10.2147/CEOR.S139950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614742/
https://www.ncbi.nlm.nih.gov/pubmed/29033594
http://dx.doi.org/10.2147/CEOR.S139950

Ejemplares similares